David Bedwell
Overview
Explore the profile of David Bedwell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
30
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Staedtke V, Anstett K, Bedwell D, Giovannini M, Keeling K, Kesterson R, et al.
Clin Trials
. 2023 Nov;
21(1):51-66.
PMID: 37937606
Numerous successful gene-targeted therapies are arising for the treatment of a variety of rare diseases. At the same time, current treatment options for neurofibromatosis 1 and schwannomatosis are limited and...
2.
Osum S, Oribamise E, Corbiere S, Taisto M, Jubenville T, Coutts A, et al.
Mol Ther Nucleic Acids
. 2023 Jul;
33:227-239.
PMID: 37520682
Neurofibromatosis type 1 (NF1) results from germline mutations in the tumor-suppressor gene and predisposes patients to developing nervous system tumors. Twenty percent of NF1 patients harbor nonsense mutations resulting in...
3.
Dressman B, Tromiczak E, Chappell M, Tripp A, Quimby S, Vetman T, et al.
Bioorg Med Chem Lett
. 2016 Nov;
26(23):5663-5668.
PMID: 27836401
Negative modulators of metabotropic glutamate 2 & 3 receptors demonstrate antidepressant-like activity in animal models and hold promise as novel therapeutic agents for the treatment of major depressive disorder. Herein...
4.
Pittman P, Norris S, Barrera Oro J, Bedwell D, Cannon T, McKee Jr K
Vaccine
. 2006 Feb;
24(17):3654-60.
PMID: 16497418
The antibody profile during and after the six-dose primary vaccination series with anthrax vaccine adsorbed (AVA, Biothrax) was characterized in 86 human volunteers. Ninety-three percent of recipients developed IgG antibodies...